Opportunities for microRNAs in the Crowded Field of Cardiovascular Biomarkers

Perry V. Halushka, Andrew J. Goodwin, Marc K Halushka

Research output: Contribution to journalReview article

Abstract

Cardiovascular diseases exist across all developed countries. Biomarkers that can predict or diagnose diseases early in their pathogeneses can reduce their morbidity and mortality in afflicted individuals. microRNAs are small regulatory RNAs that modulate translation and have been identified as potential fluid-based biomarkers across numerous maladies. We describe the current state of cardiovascular disease biomarkers across a range of diseases, including myocardial infarction, acute coronary syndrome, myocarditis, hypertension, heart failure, heart transplantation, aortic stenosis, diabetic cardiomyopathy, atrial fibrillation, and sepsis. We present the current understanding of microRNAs as possible biomarkers in these categories and where their best opportunities exist to enter clinical practice.

Original languageEnglish (US)
Pages (from-to)211-238
Number of pages28
JournalAnnual Review of Pathology: Mechanisms of Disease
Volume14
DOIs
StatePublished - Jan 1 2019

Fingerprint

MicroRNAs
Biomarkers
Cardiovascular Diseases
Diabetic Cardiomyopathies
Aortic Valve Stenosis
Myocarditis
Heart Transplantation
Acute Coronary Syndrome
Developed Countries
Atrial Fibrillation
Sepsis
Heart Failure
Myocardial Infarction
RNA
Hypertension
Morbidity
Mortality

Keywords

  • microRNAs, biomarkers, cardiovascular disease, hypertension, sepsis, aortic stenosis

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Opportunities for microRNAs in the Crowded Field of Cardiovascular Biomarkers. / Halushka, Perry V.; Goodwin, Andrew J.; Halushka, Marc K.

In: Annual Review of Pathology: Mechanisms of Disease, Vol. 14, 01.01.2019, p. 211-238.

Research output: Contribution to journalReview article

@article{809f738c0f8e47acadd912f90d73d76a,
title = "Opportunities for microRNAs in the Crowded Field of Cardiovascular Biomarkers",
abstract = "Cardiovascular diseases exist across all developed countries. Biomarkers that can predict or diagnose diseases early in their pathogeneses can reduce their morbidity and mortality in afflicted individuals. microRNAs are small regulatory RNAs that modulate translation and have been identified as potential fluid-based biomarkers across numerous maladies. We describe the current state of cardiovascular disease biomarkers across a range of diseases, including myocardial infarction, acute coronary syndrome, myocarditis, hypertension, heart failure, heart transplantation, aortic stenosis, diabetic cardiomyopathy, atrial fibrillation, and sepsis. We present the current understanding of microRNAs as possible biomarkers in these categories and where their best opportunities exist to enter clinical practice.",
keywords = "microRNAs, biomarkers, cardiovascular disease, hypertension, sepsis, aortic stenosis",
author = "Halushka, {Perry V.} and Goodwin, {Andrew J.} and Halushka, {Marc K}",
year = "2019",
month = "1",
day = "1",
doi = "10.1146/annurev-pathmechdis-012418-012827",
language = "English (US)",
volume = "14",
pages = "211--238",
journal = "Annual Review of Pathology: Mechanisms of Disease",
issn = "1553-4006",
publisher = "Annual Reviews Inc.",

}

TY - JOUR

T1 - Opportunities for microRNAs in the Crowded Field of Cardiovascular Biomarkers

AU - Halushka, Perry V.

AU - Goodwin, Andrew J.

AU - Halushka, Marc K

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Cardiovascular diseases exist across all developed countries. Biomarkers that can predict or diagnose diseases early in their pathogeneses can reduce their morbidity and mortality in afflicted individuals. microRNAs are small regulatory RNAs that modulate translation and have been identified as potential fluid-based biomarkers across numerous maladies. We describe the current state of cardiovascular disease biomarkers across a range of diseases, including myocardial infarction, acute coronary syndrome, myocarditis, hypertension, heart failure, heart transplantation, aortic stenosis, diabetic cardiomyopathy, atrial fibrillation, and sepsis. We present the current understanding of microRNAs as possible biomarkers in these categories and where their best opportunities exist to enter clinical practice.

AB - Cardiovascular diseases exist across all developed countries. Biomarkers that can predict or diagnose diseases early in their pathogeneses can reduce their morbidity and mortality in afflicted individuals. microRNAs are small regulatory RNAs that modulate translation and have been identified as potential fluid-based biomarkers across numerous maladies. We describe the current state of cardiovascular disease biomarkers across a range of diseases, including myocardial infarction, acute coronary syndrome, myocarditis, hypertension, heart failure, heart transplantation, aortic stenosis, diabetic cardiomyopathy, atrial fibrillation, and sepsis. We present the current understanding of microRNAs as possible biomarkers in these categories and where their best opportunities exist to enter clinical practice.

KW - microRNAs, biomarkers, cardiovascular disease, hypertension, sepsis, aortic stenosis

UR - http://www.scopus.com/inward/record.url?scp=85060540879&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060540879&partnerID=8YFLogxK

U2 - 10.1146/annurev-pathmechdis-012418-012827

DO - 10.1146/annurev-pathmechdis-012418-012827

M3 - Review article

C2 - 30332561

AN - SCOPUS:85060540879

VL - 14

SP - 211

EP - 238

JO - Annual Review of Pathology: Mechanisms of Disease

JF - Annual Review of Pathology: Mechanisms of Disease

SN - 1553-4006

ER -